Health Boards
Mon-26-04-2021, 00:29 AM
They might have to lower the dose a bit. Clearance is not so great if it increases risk. Always hard finding a balance.
|
Bimekizumab phase 3 studies in psoriasis
|
|
« Next Oldest | Next Newest »
|
| Messages In This Thread |
|
Bimekizumab phase 3 studies in psoriasis - by Fred - Sat-24-04-2021, 11:31 AM
RE: Bimekizumab phase 3 studies in psoriasis - by Turnedlight - Sat-24-04-2021, 16:09 PM
RE: Bimekizumab phase 3 studies in psoriasis - by Bill - Mon-26-04-2021, 00:29 AM
|
| Possibly Related Threads… | |||||
| Thread | Author | Replies | Views | Last Post | |
|
Phase 1b Trial of VYN202 for psoriasis | Fred | 2 | 662 |
Tue-25-02-2025, 12:15 PM Last Post: Fred |
|
|
CAL101 phase 1 on patients with psoriasis | Fred | 6 | 2,232 |
Fri-25-10-2024, 15:51 PM Last Post: Fred |
|
|
Piclidenoson for psoriasis phase 3 results | Fred | 1 | 3,983 |
Fri-02-02-2024, 20:04 PM Last Post: Caroline |
|
|
JNJ-2113 for psoriasis Phase 2b results | Fred | 4 | 4,420 |
Wed-12-07-2023, 11:52 AM Last Post: Turnedlight |
|
|
Piclidenoson for psoriasis report before phase 3 data release | Fred | 0 | 1,826 |
Fri-14-01-2022, 15:24 PM Last Post: Fred |
Users browsing this thread: 1 Guest(s)